Clinical Trial Update: Ketamine Infusion for Pediatric Patients With Obstructive Sleep Apnea Syndrome (OSAS) After Tonsillectomy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating ketamine infusion for pediatric patients with obstructive sleep apnea syndrome after tonsillectomy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obstructive Sleep Apnea Syndrome

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: University of Manitoba | Conditions: Obstructive Sleep Apnea Syndrome | Phase 4 | Status: COMPLETED